Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by freedom2020on Dec 18, 2015 7:50pm
330 Views
Post# 24397133

RE:January conference CIBC

RE:January conference CIBC
I forgot to post the source was from a recent "McGraw Hill Financial S&P Capital IQ" Prometic report, the "key developments" section of the report.  This report came through from TD webroker it's copyright so I can't post it.



freedom2020 - (12/18/2015 7:20:27 PM) 
January conference CIBC
 
Interesting looks like Prometic will be presenting at the CIBC 19th Annual Whistler Institutional Investor Conference 2016, Jan-20-2016 at 04:35 PM.
 
From CIBC site:
 
"By bringing the investor community together with senior executives of major public and private companies and our top-ranked industry analysts for in-depth discussions, our investor conferences have developed a well-earned reputation within the financial community as "must-attend" events."
 
"All conferences are by invitation only"

Bullboard Posts